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Abstract 
This presentation will cover three projects in interpretation of human genomic variation. 
We have developed an analysis protocol whose distinctive features enabled solving 
clinical cases. Applied to exomes from newborn patients with undiagnosed primary 
immune disorders, it helped guide appropriate treatment, family genetic counseling, and 
avoidance of diagnostic odyssey. 
 
This inspired a project that explores the feasibility of sequencing to augment or 
supersede mass spectrometry for pervasive public health newborn screening. We 
sequenced exomes from de-identified dried blood spots of nearly all newborns affected 
with any metabolic disorder screened by tandem mass-spectroscopy (MS/MS) in 
California from 2006 to 2013 (around 1300 out of around 4.45 million screened). Our 
preliminary analysis indicates that several affected individuals lack any obviously 
damaging mutations in genes responsible for their metabolic disorders. We also found 
some cases where exomes confidently implicated a disorder different from the original 
diagnosis by the metabolic center clinician, suggesting that sequencing information 
would have been valuable for proper clinical diagnoses in some cases. While still not 
sufficiently specific to used alone for screening of all inborn errors of metabolism, 
exomes could facilitate timely and more precise clinical resolution for some disorders. 
To conclude, I will briefly present results from The Critical Assessment of Genome 
Interpretation (CAGI, \'kā-jē\), a community experiment to objectively assess 
computational methods for predicting the phenotypic impacts of genomic variation. 
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